Category - New Drugs
FDA Approves Ryzumvi (phentolamine) Ophthalmic Solution for the Treatment of Pharmacologically-Induced Mydriasis
FDA Approves Likmez (metronidazole) Oral Suspension for the Treatment of Parasitic and Anaerobic Bacterial Infections
US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease
RedHill Announces FDA sNDA Approval for Simplified Dosage Regimen for Talicia
FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
FDA Approves New and Updated Indications for Temozolomide Under Project Renewal
FDA Approves Aphexda (motixafortide) to Mobilize Hematopoietic Stem Cells for Autologous Transplantation in Patients with Multiple Myeloma
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine